Alan R Rein

Title: Alan R Rein: Innovator in HIV-1 Inactivation

Introduction

Alan R Rein is a notable inventor based in Takoma Park, MD (US). He has made significant contributions to the field of virology, particularly in the development of methods to combat HIV-1. His innovative approach focuses on identifying compounds that can effectively inactivate retroviruses.

Latest Patents

Alan R Rein holds a patent for a "Method for identifying and using compounds that inactivate HIV-1." This invention provides several classes of compounds that target the CCHC zinc fingers of the viral nucleocapsid protein, effectively ejecting zinc from the protein. The patent also includes the development of kits designed to identify compounds that can react with these zinc fingers, allowing for the screening and identification of potential therapeutic agents against various retroviruses.

Career Highlights

Rein's career is marked by his dedication to advancing medical science through innovative research. He has worked with the United States of America as represented by the Department of Health, contributing to public health initiatives aimed at combating viral infections. His work has the potential to impact the treatment of HIV-1 significantly.

Collaborations

Throughout his career, Alan R Rein has collaborated with esteemed colleagues, including Louis E Henderson and Larry O Arthur. These partnerships have fostered a collaborative environment that enhances the research and development of effective antiviral strategies.

Conclusion

Alan R Rein's contributions to the field of virology, particularly in the inactivation of HIV-1, highlight his role as an innovative inventor. His patented methods and collaborative efforts continue to pave the way for advancements in antiviral therapies.